Search - tctmd.com

Displaying 41 - 60 of 112

Sort: Relevancy | Date

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

CVD, Diabetes Spike in Acute Phase of COVID-19

Todd Neale

July 19, 2022

News Daily News

‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health

L.A. McKeown

July 04, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

Advertisement

June 2023 News Roundup

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

March 2023 News Roundup

January 2023 News Roundup

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

CVD, Diabetes Spike in Acute Phase of COVID-19

‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Fewer Diabetic Complications Seen When NOACs Given for AF

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

November 2021 News Roundup

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content